AI SummaryBeta
StimCardio Medical recently closed a $30 Million oversubscribed Series A to advance atrial fibrillation treatment. The company has been a member since November 2026 and focuses on investing in innovative medical solutions.
AI-generated from Traded deal data. May contain errors.
About
StimCardio Medical is a clinical-stage medical device company based in Los Angeles, specializing in non-invasive wearable therapeutics for cardiac rhythm management, particularly atrial fibrillation. The company recently secured $30 million in a Series A funding round to advance its innovative wearable device, Rhyvive.
Markets
Headquarters
12130 Millennium Drive Suite 300
Member since: November 2026
Deals
Transaction Type
Asset Type
State
Sort By
RAISE
StimCardio Medical Closes $30 Million Oversubscribed Series A To Advance Atrial Fibrillation Treatment
CRE
AZ
TH
Oct 23, 2026